As always, it can be hit-and-miss. Last year’s top stock picker Rikki Bannon chose Telix Pharmaceuticals, which makes prostate cancer imaging drug Illuccix. It has risen 150 per cent since.
Jonathan Shapiro writes about banking and finance, specialising in hedge funds, corporate debt, private equity and investment banking. He is based in Sydney. Connect with Jonathan on Twitter. Email Jonathan at jonathan.shapiro@afr.com
Daniel Arbon is deputy newsletter editor for The Australian Financial Review. Email Daniel at daniel.arbon@nine.com.au